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Radiation treatment for cancer is associated with an increased risk of cardiovascular 
disease. Animal studies report decreases in endothelial vasodilator function in radiated arteries, 
however, there remains limited knowledge about the intact human circulation. Therefore, the aim 
of the present study was to determine the acute and chronic effects of radiation therapy on 
cutaneous microvascular reactivity in breast cancer patients. METHODS: The present study 
utilized a cross-sectional study design in 7 breast cancer patients receiving radiation therapy and 
13 survivors > 3 years post-radiation therapy. Cutaneous microvascular reactivity to 
acetylcholine (ACh) was evaluated following radiation exposure at the site of radiation treatment 
and at a contralateral control non-radiated site. Red blood cell flux was measured as an index of 
cutaneous blood flow via laser Doppler flowmetry with ACh-mediated vasodilation determined 
by iontophoresis drug delivery. Cutaneous vascular conductance (CVC) was calculated by 
normalizing for mean arterial pressure. RESULTS: %CVC to incremental ACh was significantly 
attenuated in the radiated compared to non-radiated tissue following a total cumulative dose of 
2104±236 cGy within the patients currently receiving radiation. In the survivors (6475±70 cGy) 
there were no differences between radiated and non-radiated tissue. However, the peak %CVC in 
the cancer survivors was significantly lower compared to the non-radiated tissue of the cancer 
patients. CONCLUSION: This study demonstrates that radiation for cancer treatment attenuate 
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Chapter 1 - Introduction 
Over 50% of cancer patients receive radiation treatment, which has significantly 
contributed to increased cancer survival rates (Delaney et. al. 2005). However, secondary to 
decreasing cancer recurrence, radiation treatment has been shown to increase significantly the 
risk of adverse cardiovascular outcomes, particularly coronary artery disease, myocardial 
infarction, and hypertension in patients who received thoracic or chest wall radiation therapy 
(Paszat et. al. 2007, Darby et.al. 2013, Clarke et. al. 2005). As such, Clarke et. al. (2005) reports 
that there is a > 25% increase in the risk of cardiac deaths within radiated cancer patients, which 
highlights the importance of understanding the pathophysiology of radiation-induced toxicity 
within the cardiovascular system. 
 
Consequent to the increased cardiovascular disease risk, radiation exposure elicits 
numerous adverse vascular consequences, particularly vascular endothelial injury (Darby et. al. 
2013, Seddon et al. 2002), which may potentiate the development of early atherosclerotic 
cardiovascular disease (Venkatesulu et. al. 2018, Medonca et. al. 2011). Previous in vivo/vitro 
animal studies have shown a significantly decreased endothelial-dependent relaxation in radiated 
arteries within days to weeks following exposure (Menendez et. al. 1998, Qi et. al. 1998, 
Maynard et. al. 1992), with work in human cancer survivors demonstrating decreases in large 
artery vascular function years after radiation treatment (Beckman et. al. 2001, Sugihara et. al. 
1999). Specifically, Beckman et. al. (2001) investigated the flow-mediated endothelial-
dependent vasodilation responses in the axillary artery of breast cancer survivors who had a prior 
history of unilateral radiation therapy. They observed a significant attenuation in vasodilatory 
responses within radiated arteries when compared with the contralateral, non-radiated arteries. 
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These findings compliment work from Sugihara et. al. (1999) that demonstrated, in vitro, a 
decreased endothelial-dependent vasodilation in cervical arteries taken from cancer survivors 
exposed to radiation. These initial studies in axillary and cervical arteries provide valuable 
insight into endothelial dysfunction elicited by radiation therapy in cancer patients. However, 
there is a paucity in our understanding regarding the pathophysiology of radiation-induced 
endothelial dysfunction in the early radiation treatment process, particularly within the 
microcirculation. This is a critical knowledge gap given decreases in microvascular function 
occur early in the progression of numerous cardiovascular and metabolic diseases (Fernlund et. 
al. 2015, Patik et. al. 2015). As such, the evaluation of microvascular function in patients 
actively receiving radiation therapy will provide valuable insight into the adverse cardiovascular 
adaptations that occur with radiation exposure. Given the prolonged effects of radiation therapy 
mentioned above, it is critical to understand microvascular function years after radiation 
exposure. Therefore, the primary aim of this study was to determine the acute and chronic effects 
of localized radiation treatment on cutaneous microvascular function in breast cancer patients. 
We hypothesized that the endothelial-dependent vasodilatory response to acetylcholine (ACh) 
would be blunted within radiated tissue when compared to the contralateral, non-radiated tissue 
in breast cancer patients. We chose to evaluate cutaneous microvascular function as it has 
previously been used to better understand the pathophysiological role of vascular dysfunction in 
heart failure, atherosclerosis, coronary artery diseases, peripheral vascular diseases, type 2 
diabetes, and chemotherapy-induced cardiotoxicity (Sutterfield et. al. 2018, Cui et. al. 2005, 
Farkas et. al. 2004, Heitzer et.al. 2001, Rossi et al. 2004, Verma et. al. 2003, Walther et. al. 
2015). In addition, the skin receives the highest doses of radiation during treatment and, 
therefore, is more susceptible to radiation-induced injury (Jaschke et. al. 2017). 
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Chapter 2 - Methods 
Participants 
 
Seven women currently receiving unilateral chest adjunctive radiation therapy for breast 
cancer and thirteen women whom were cancer survivors that received similar unilateral 
adjunctive radiation therapy for breast cancer participated in the study. Cancer diagnosis, site of 
radiation treatment, dosage, and duration were confirmed by each patient’s treating oncologist 
and radiologist. Patients were excluded from this study if they had known atherosclerotic 
cardiovascular disease.  All procedures were approved by the Institutional Review Board of 
Kansas State University and conformed to the standards set by the Declaration of Helsinki. 




All tests were performed in a controlled temperature room (21-23°C) after a 5-10 minute 
period of supine rest. Patients remained in the supine position throughout all testing procedures. 
Cutaneous microvascular reactivity of the upper portion of both the radiated and contralateral 
non-radiated chest was determined with integrated laser Doppler flowmeter (PeriFlux 5010 laser-
Doppler perfusion monitor; Perimed, Jarfalla, Sweden), combined with iontophoresis of ACh. 
This system allows for continuous measurements of cutaneous red blood cell flux, which was 
used as an index of cutaneous blood flow (CBF) and was calibrated according to the 
manufacturers’ speciation with Brownian motility standard solution (Perimed). In each patient, 
the iontophoresis drug delivery probe (Perimed: PF 383) with an integrated laser Doppler probe 
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and temperature regulator was placed over the 3rd or 4th intercostal space along the mid-
clavicular line of both the radiated tissue and contralateral tissue, approximately 15cm away 
from the conductive hydrogel drug dispersive electrode (Perimed: PF 384). The temperature 
regulator located around the perimeter of the probe maintained local skin temperature of 33°C 
throughout the duration of the test. Following a 1-minute baseline, a 200 µL of a 2% ACh 
solution was delivered in seven successive 20-second iontophoresis doses within a 60 second 
interval. A 5-minute recovery was recorded after the seventh dose to ensure the peak 
vasodilatory response was reached. This delivery protocol is consistent with our previous work 
and has been shown to elicit no detectable current-induced axon-mediated vasodilation (Loader 
et. al. 2017). Intensity, duration, and intervals of the current delivery were controlled by a USB 
power supply (PF 751, Perimed, Järfälla, Sweden) connected to both the drug dispersive and 
drug delivery probes was managed and confirmed with the systems software (PeriIont Software; 
Perimed). Throughout the test beat-by-beat blood pressure was continuously measured 
throughout each visit via photoplethysmography (Finometer Pro, Finapres Medical Systems, 
Amsterdam, The Netherlands). Unless restricted by lymph node dissection or lymphedema, 




Cutaneous blood flow was recorded at 100 Hz by data acquisition software (DI-720, 
DATAQ Instruments, Akron, OH, USA) and reported in arbitrary perfusion units (PU). Baseline 
averages were calculated over a 1-minute rest interval for CBF and MAP. Cutaneous blood flow 
responses to ACh were binned in 10-second averages, from which peak values were identified 
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for each ACh iontophoresis delivery dose. To normalize for MAP, cutaneous vascular 
conductance (CVC, PU/mmHg) was calculated as: (PU/MAP) x 100. The relative change in 
CVC from baseline to each peak dose response was calculated as: [(peak-baseline CVC)/baseline 




Statistical analyses were performed using a commercially available software package 
(Prism 8, GraphPad Software, San Diego, CA, USA). Pair differences between radiated and non-
radiated tissues were determined by independent samples t-tests. Peak CVC responses were 
compared between patients with 2-way repeated ANOVA. All data are presented as mean ± SE, 





Chapter 3 - Results 
 
Seven postmenopausal women scheduled to receive daily, unilateral radiation treatment 
for breast cancer were enrolled in the study. Participants were aged 65.7 ± 5.1 years, had a 
resting MAP of 99.4 ± 8.2 mmHg, and body mass index of 28.4 ± 5.7 kg/m2. The average 
fractional dose of radiation received was 209 ± 9 cGy, with the average cumulative dose of 
radiation at the time of the study was 2104 ± 236 cGy. Five patients received radiation to the left 
breast. Three patients had received chemotherapy prior to the initiation of radiation treatment. 
No patients were currently taking Tamoxifen, one was taking Anastrozole, two were on statins 
and three were on hypertension medication at the time of the study. 
 
Resting CVC in the cancer patients was 11.0 ± 4.1 PU/mmHg and 10.7 ± 2.9 PU/mmHg 
for radiated and non-radiated tissue, respectively (P = 0.96). A significantly lower endothelial-
dependent vasodilation was observed at each dose of ACh administration within the radiated 
tissue when compared to non-radiated contralateral tissue in breast cancer patients currently 
receiving radiation therapy (P=0.03) (Figure 1), with the peak %CVC in response to ACh being 
significantly lower in radiated tissue compared to non-radiated (radiated: 506 ± 167 %, non-
radiated: 983 ± 223 %; P = 0.02). 
 
A second cohort of thirteen postmenopausal women with a history of unilateral radiation 
therapy for breast cancer were also enrolled. Participants were aged 55.9 ± 10.7 years, had a 
resting MAP of 94.0 ± 7.8 mmHg, and body mass index of 31.0 ± 6.7 kg/m2. The average length 
of time between last radiation treatment and enrollment was 6.9 ± 1.2 years. The average 
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cumulative dose of radiation in the cancer survivors was 6475 ± 70 cGy. Nine cancer survivors 
had received radiation to the left breast. Twelve survivors had received chemotherapy. Seven 
survivors were currently taking Tamoxifen, three were taking Anastrozole, three on statins and 
six on hypertension medication at the time of the study. Three survivors’ radiation total dosage 
and drug information were unavailable.  
 
Resting CVC in the cancer survivors was 9.2 ± 1.5 PU/mmHg and 11.4 ± 3.4 PU/mmHg 
for radiated and non-radiated tissue, respectively (P = 0.50). No difference in endothelial-
dependent vasodilation to ACh was observed within the radiated tissue when compared to non-
radiated contralateral tissue (P = 0.4) (Figure 2). Similarly, with the peak %CVC in response to 
ACh was similar between radiated tissue and non-radiated tissue (radiated: 506 ± 76 %, non-
radiated: 558 ± 81 %; P = 0.25). To evaluate the acute and chronic effects of radiation treatment, 
the peak %CVC response for the cancer patients and cancer survivors were compared (Figure 3). 
The peak %CVC was lower in the radiated and non-radiated tissue of the cancer survivors 
compared to the non-radiated tissue of the current cancer patients. There were no differences 
between peak %CVC in the radiated tissue of the current cancer patients and that observed in 
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Figure 1 - Relative increase in cutaneous vascular conductance (%CVC) in response to 
incremental ACh iontophoresis doses in cancer patients currently receiving radiation therapy. 
%CVC was significantly lower in the radiated tissue compared to non-radiated tissue. * Denotes 
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Figure 2 - Relative increase in cutaneous vascular conductance (%CVC) in response to 
incremental ACh iontophoresis doses in cancer survivors with a history of radiation therapy. 
%CVC was not significantly different between radiated and non-radiated tissue. Values are 
mean±SE. 
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Figure 3 - Peak increase in cutaneous vascular conductance (%CVC) in response to 
acetylcholine. Note the significantly lower response in the non-radiated and radiated tissue of the 
cancer survivors compared to the non-radiated tissue in cancer patients. # denotes significantly 







Chapter 4 - Discussion 
The major finding in the present study was that cutaneous microvascular endothelial-
dependent vasoreactivity was lower in radiated tissue when compared to non-radiated tissue in 
breast cancer patients. Specifically, dose-dependent decreases in ACh-mediated vasodilation 
were observed within radiated tissue compared with contralateral, non-radiated tissue. These 
finding suggest that radiation has a negative impact on microvascular endothelial-dependent 
vasoreactivity, which may contribute to an increased risk of adverse cardiovascular events as 
previously suggested (Darby et. al. 2013, Suddon et. al. 2002, Hooning et. al. 2007). To the best 
of our knowledge, this is the first study investigating the effects of radiation on cutaneous 
microvasculature within human cancer patients currently undergoing radiation therapy.  
 
The present study demonstrates significant decreases in cutaneous endothelial function 
during radiation therapy. Given the established early role for microvascular dysfunction in the 
progression of numerous cardiovascular and metabolic disease (Fernlund et. al. 2015, Patik et. al. 
2015, and Verma et. al. 2003), these findings provided added insight into the changes in 
cardiovascular health associated with radiation therapy. While the regulation of the cutaneous 
circulation is somewhat different compared to other vascular bed, previous work has proposed it 
as a model of generalized microvascular function (Holowatz et. al. 2008), given that it is 
correlated with coronary vascular function (Khan et. al. 2008) and has been used to predict 
cardiac events in coronary artery disease patients (Heitzer et. al. 2001). This work, therefore, is 
clinically significant given reports of accelerated atherosclerosis, leading to severe coronary 
artery disease, following chest radiotherapy (Cheng et. al. 2017; Lee et. al. 2013; Hull et. al. 
2003).    
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In addition to the development of arterial disease, radiation therapy significantly 
compromises wound healing, which may be due, in part, to changes in endothelial function 
(Haubner et. al. 2012; Jacobson et. al. 2017). Lee et al. (1999) has previously demonstrated a key 
role for eNOS in wound repair. In eNOS knockout mice, excisional wound closure and incisional 
wound strength were significantly impaired compared to wild-type mice. In addition, they 
demonstrated that eNOS facilitated growth factor-stimulated angiogenesis. Given, that ACh-
mediated vasodilation in the cutaneous circulation is mediated, in part, by eNOS production of 
NO, the findings of the present study suggest that impaired wound healing may occur early in 
radiation treatment. These findings are consistent with reports of decreased NO expression in 
wounds of animals exposed to 12 and 24 Gy radiation (Schaffer et. al. 2002). As such, 
assessment of the cutaneous microcirculation during and following radiation treatment may 
provide valuable insight into a patient’s risk of wound healing complications.  
 
Our group and others have used laser Doppler flowmetry with iontophoretic 
administration of ACh to evaluate microvascular endothelial reactivity in response to cancer 
therapies and a variety of cardiovascular disease (Medow et. al. 2005, Rodriguez-Miguelez et. al. 
2016, Walther et. al. 2015). Administration of exogenous ACh causes an endothelial-dependent 
vasodilation in the skin primarily through the actions of nitric oxide (NO) and prostaglandins 
(Kellogg et. al. 2005, Medow et. al. 2008, Khan et. al. 1997, Noon et. al. 1998, Holowatz et. al. 
2005), with reports of some contributions of endothelial-derived hyperpolarizing factor (EDHF) 
(Brunt et. al. 2015). Kellogg et al. (2005) demonstrated that both NO- and prostaglandin-
dependent pathways are used in the vasodilatory response to ACh.  Conversely, Holowatz et. al. 
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(2005) suggest that ACh mediates cutaneous vasodilation via primarily prostaglandin and non-
NO-dependent pathways. These authors observed no differences in peak vasodilation during 
ACh administration following administration of eNOS inhibitors, but was significantly reduced 
when cyclooxygenase (COX) was inhibited. Thus, when ACh binds to muscarinic receptors on 
the surface of endothelial cells it activates not only G-proteins, resulting in the NOS pathway, in 
which L-arginine is converted to NO, but also stimulates the production of prostaglandins. While 
the relative contribution of these factors remains somewhat contested, the primary mechanism 
for ACh- mediated cutaneous vasodilation is via endothelial-dependent factors. Therefore, our 
data demonstrates a significant decrease in endothelial-dependent cutaneous microvascular 
vasodilation, with further work needed to more completely elucidate the exact signaling 
pathways impacted.  
 
Radiation is believed to decrease vasoreactivity due to the increased superoxide (O2
-) 
production that is caused from the radiation induced cellular damage, and thus attenuates the 
eNOS pathway by O2
- blinding to NO, creating peroxynitrate (ONOO-), decreasing NO 
bioavailability, and ultimately decreasing the vasoreactivity response (Baselet et.al. 2018). A 
decrease in ACh-induced NO-mediated vasodilation has been shown in rats receiving radiation 
(Hatoum et. al. 2006). Additionally, a decrease in eNOS expression in radiated arteries has been 
observed by Sugihara et. al. (1999) within human cervical arteries radiated with an average of 
4790 cGy when compared to non-radiated control vessels. Similarly, Qi et. al. (1998) observed a 
significantly decreased, but not eliminated, expression of eNOS in rabbit ear arteries following 
4500 cGy irradiation when compared to non-radiated arteries at both 1 and 4 weeks post 
radiation ( ~69 % and ~70% decreased relative to control, respectively). Complimenting these 
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finding, Holler et. al. (2009) observed a decreases in eNOS expression following both 1000 cGy 
and 4500 cGy doses of radiation in mice. These findings support a significant decreases in eNOS 
at both low and high therapeutic radiation doses, which may contribute to the decreased ACh-
mediated vasodilation observed in the present study. There is, however, a potential to restore 
eNOS function as Holler et. al. (2009) investigated the effects of pravastatin on endothelial 
function. They observed a restoration in eNOS levels within 4500 cGy radiated tissue when 
administered pravastatin compared to 4500 cGy radiation alone. The expression of eNOS within 
the radiated tissue combined with pravastatin expressed an average of 11.8 positive vessels per 
field, whereas radiation only expressed 5.6 positive vessels per field. Additionally, they found a 
decrease in eNOS levels at 3, 7, and 14 days post 1000 cGY radiation when compared to radiated 
treated with pravastatin using western blot analysis. This suggests the potential of restoring 
eNOS expression in radiated tissues. In addition to reductions in eNOS expression, prostacyclin 
(PGI2) expression has been shown to be blunted within radiated cells when compared to non-
radiated, bystander cells (Allen et. al. 1981). However, EDHF pathway in cutaneous tissue is 
thought to be relatively resistant to radiation (Soloviev et. al. 2003). These findings in total 
suggest a that the reduction in vascular vasodilator capacity is a consequence of decreases in NO 
and PGI2 dependent pathways, and that the EDHF allows for some maintenance of vasodilator 
function following radiation exposure. 
 
Previous research in animals exposed to high and low radiation levels have demonstrated 
significant decreases in endothelial dependent vascular function (Qi et. al. 1998, Soloviev et. al. 
2003, Maynard et. al. 1992, Hatoum et. al. 2006, On et. al. 1998, Menendez et. al. 1998). 
Hatoum et al. (2006) removed submucosal intestinal arteries from radiated rats, and 
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demonstrated an attenuated response to ACh-mediated vasodilation following the second 
fractional dose of 250 cGy. Importantly, they also observed high levels of superoxide within the 
radiated vessels when compared to those of the controls. These increased superoxide levels were 
observed at each radiation dose. In agreement with these findings, On et. al. (1998) found ACh-
induced relaxation of the thoracic aorta was significantly decreased in radiated rats (1000 cGy) 
when compared to healthy controls, but was prevented when rats were supplemented with the 
antioxidant vitamin C. This prevention of radiation induced endothelial dysfunction by 
pretreatment with vitamin C supports the role of oxidative damage as a potential underlying 
mechanism.  
 
Currently there is limited information of the effects of therapeutic levels of radiation on 
endothelial dependent vascular health in the human population. Sugihara et. al. (1999) examined 
ACh-mediated relaxation in cervical arteries taken from the neck region of cancer patients who 
received on average 4790 cGy of radiation therapy. The maximum ACh-mediated vasodilatory 
response was significantly diminished (~70%) in radiated arteries compared with controls. In 
addition, Beckman et. al. (2001) evaluated the effects of radiation treatment on the flow-
mediated vasodilator response in radiated axillary arteries in breast cancer survivors who 
received radiation therapy at least 3 years prior to the study. They showed a diminished flow-
mediated dilation when compared to contralateral non-radiated axillary arteries and arteries of 
healthy age-matched controls. Similar to the work of Beckman et.al. (2001) we compared 
radiated and non-radiated vasculature within the same patient, to minimize the effects of variable 
confounders between patients. Our findings expand on this early work by demonstrating an 
attenuated ACh-mediated endothelial-dependent vasodilation within the radiated cutaneous 
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microvasculature. Thus, our work in combination with the previous findings of Beckman et. al. 
(2001) and Sugihara et. al. (1999), demonstrate that radiation induces significant decreases in 
endothelial-dependent micro- and macrovascular function, that based on the present study occurs 
very early in the radiation treatment process.  
 
Long term effects of radiation treatment on endothelial-dependent vasoreactivity have 
previously been demonstrated in animal models. Maynard et. al. (1992) investigated the relaxant 
responses within rabbit ear arteries at 6 weeks post a single dose of 4500 cGy radiation, which is 
equivalent to ~3.75 human years (Andreollo et. al. 2012). These authors demonstrated that ACh-
mediated endothelial-dependent relaxation remained significantly decreased when compared to 
age-matched controls despite the extended duration post-radiation. Similarly, Qi et. al. (1998) 
found that percent relaxation to ACh was significantly blunted in rabbit ear arteries after 6 and 
10 weeks post 4500 cGy irradiation. Complementing these findings, Menendez et. al. (1998) 
explored the acute and chronic effects of radiation on ACh mediated dilation in the rodent 
abdominal artery. They observed that abdominal vessels extracted at 6 months post radiation 
showed significant decreases in ACh mediated relaxation compared to nonradiated thoracic 
vessels of the same animal. This response was similar to that observed in animals investigated 72 
hr post radiation, highlighting the potential long-term effects of radiation on endothelial-
dependent relaxation. In humans receiving radiation, Beckman et. al. (2001) is the only study to 
our knowledge that has investigated the effects of radiation therapy on the axillary artery in 
breast cancer survivors with an average length of 12 ± 6 years post radiation. Using flow 
mediated dilation of the axillary artery, radiated arteries showed a significantly decreased percent 
vasodilation when compared to contralateral, non-radiated axillary arteries and matched healthy 
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controls, ultimately decreasing endothelial function. Important to the interpretation of their study, 
only nine of the sixteen (~56%) of the breast cancer patients studied had a history of cancer 
chemotherapy treatment. This is an important point, given that previous studies have shown 
decreased vasoreactivity in patients undergoing chemotherapy. Patients currently treated with 
Paclitaxel chemotherapy demonstrated a reduction in flow mediated dilation when compared to 
controls (Vassilakopoulou et. al. 2010). Similarly, Sutterfield et. al. (2018) observed a decreased 
response in flow mediated dilation within the cancer patients receiving chemotherapy when 
compared to matched controls. Additionally, cutaneous vascular conductance was attenuated 
within the cancer patients when compared to controls, demonstrating an impairment in 
microvascular function. Previous work in cancer survivors 24.6 ± 4.8 years post chemotherapy 
demonstrated a significantly lower flow mediated dilation response when compared to healthy 
controls (Dengel et. al. 2008). In the present study, twelve of the thirteen cancer survivors 
(~92%) had previously received chemotherapy. Therefore, the overall decreased response in the 
cancer survivors at the radiated and non-radiated tissues is likely attributed to the systemic 
vascular effects of chemotherapy.  
 
There are several experimental considerations regarding this study. First, some of the 
patients in the present study also received chemotherapy, which has previously been shown to 
decrease cutaneous microvascular function (Sutterfield et. al. 2018). Since the effects of 
chemotherapy are systemic and patients served as their own control, this allowed these patients 
to be included in the study. Second, the population measured in this study was strictly female 
breast cancer patients, therefore these results are not representative of cancer patient population 
in its entirety. Radiation treatment is the most commonly used therapeutic intervention for men 
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diagnosed with prostate cancer and therefore, may experience similar decreases in cutaneous 
microvascular function (Michaelson et. al. 2008, Arcangeli et. al. 2012). Third, iontophoresis of 
ACh, can elicit a nonspecific axon reflex vasodilation. However, we utilized previously reported 
low current density delivery protocols, which eliminates the impact of nonspecific axon reflexes 
(Sutterfield et. al. 2018, Rodriguez-Miguelez et. al. 2016, Walther et. al. 2015 Hamdy et. al. 
2001). Lastly, we were unable to heat the skin to evaluate cutaneous microvascular vasodilation, 
which is primarily NO dependent (Kellogg et. al. 2005), due to the increased risk of injury 
associated with heating the radiated skin.  
 
In conclusion, the present study demonstrates that endothelial-dependent vasoreactivity 
within microvascular beds is attenuated in breast cancer patients currently receiving radiation 
therapy. There was no change between the radiated and non-radiated tissues in the cancer 
survivors, however an attenuated response was observed within the non-radiated tissue of the 
cancer survivors when compared to patients currently receiving radiation. Taken together these 
findings suggest that patients undergoing radiation therapy experience decreased vasoreactivity 
within radiated tissue which may contribute to the increased long-term risk of cardiovascular 






Chapter 5 - References 
 
Allen, J. B., Sagerman, R. H., & Stuart, M. J. (1981). Irradiation decreases vascular prostacyclin 
formation with no concomitant effect on platelet thromboxane production. Lancet, 
2(8257), 1193-1196.  
 
Andreollo, N. A., Santos, E. F., Araújo, M. R., & Lopes, L. R. (2012). Rat's age versus human's 
age: what is the relationship? Arq Bras Cir Dig, 25(1), 49-51.  
 
Arcangeli, S., Pinzi, V., & Arcangeli, G. (2012). Epidemiology of prostate cancer and treatment 
remarks. World J Radiol, 4(6), 241-246. doi:10.4329/wjr.v4.i6.241 
 
Baselet, B., Sonveaux, P., Baatout, S., & Aerts, A. (2019). Pathological effects of ionizing 
radiation: endothelial activation and dysfunction. Cell Mol Life Sci, 76(4), 699-728. 
doi:10.1007/s00018-018-2956-z 
 
Beckman, J. A., Thakore, A., Kalinowski, B. H., Harris, J. R., & Creager, M. A. (2001). 
Radiation therapy impairs endothelium-dependent vasodilation in humans. J Am Coll 
Cardiol, 37(3), 761-765.  
 
Brunt, V. E., Fujii, N., & Minson, C. T. (2015). Endothelial-derived hyperpolarization 
contributes to acetylcholine-mediated vasodilation in human skin in a dose-dependent 
manner. J Appl Physiol (1985), 119(9), 1015-1022. doi:10.1152/japplphysiol.00201.2015 
 
Cheng, Y. J., Nie, X. Y., Ji, C. C., Lin, X. X., Liu, L. J., Chen, X. M., . . . Wu, S. H. (2017). 
Long-Term Cardiovascular Risk After Radiotherapy in Women With Breast Cancer. J 
Am Heart Assoc, 6(5). doi:10.1161/JAHA.117.005633 
 
Clarke, M., Collins, R., Darby, S., Davies, C., Elphinstone, P., Evans, V., . . . (EBCTCG), E. B. 
C. T. C. G. (2005). Effects of radiotherapy and of differences in the extent of surgery for 
early breast cancer on local recurrence and 15-year survival: an overview of the 
randomised trials. Lancet, 366(9503), 2087-2106. doi:10.1016/S0140-6736(05)67887-7 
 
Cui, J., Arbab-Zadeh, A., Prasad, A., Durand, S., Levine, B. D., & Crandall, C. G. (2005). 
Effects of heat stress on thermoregulatory responses in congestive heart failure patients. 
Circulation, 112(15), 2286-2292. doi:10.1161/CIRCULATIONAHA.105.540773 
 
Darby, S. C., Ewertz, M., McGale, P., Bennet, A. M., Blom-Goldman, U., Brønnum, D., . . . 
Hall, P. (2013). Risk of ischemic heart disease in women after radiotherapy for breast 
cancer. N Engl J Med, 368(11), 987-998. doi:10.1056/NEJMoa1209825 
 
Delaney, G., Jacob, S., Featherstone, C., & Barton, M. (2005). The role of radiotherapy in cancer 
treatment: estimating optimal utilization from a review of evidence-based clinical 
20 
guidelines. Cancer, 104(6), 1129-1137. doi:10.1002/cncr.21324 
 
Dengel, D. R., Ness, K. K., Glasser, S. P., Williamson, E. B., Baker, K. S., & Gurney, J. G. 
(2008). Endothelial function in young adult survivors of childhood acute lymphoblastic 
leukemia. J Pediatr Hematol Oncol, 30(1), 20-25. doi:10.1097/MPH.0b013e318159a593 
 
Farkas, K., Kolossváry, E., Járai, Z., Nemcsik, J., & Farsang, C. (2004). Non-invasive 
assessment of microvascular endothelial function by laser Doppler flowmetry in patients 
with essential hypertension. Atherosclerosis, 173(1), 97-102. 
doi:10.1016/j.atherosclerosis.2003.11.015 
 
Fernlund, E., Schlegel, T. T., Platonov, P. G., Carlson, J., Carlsson, M., & Liuba, P. (2015). 
Peripheral microvascular function is altered in young individuals at risk for hypertrophic 
cardiomyopathy and correlates with myocardial diastolic function. Am J Physiol Heart 
Circ Physiol, 308(11), H1351-1358. doi:10.1152/ajpheart.00714.2014 
 
Hamdy, O., Abou-Elenin, K., LoGerfo, F. W., Horton, E. S., & Veves, A. (2001). Contribution 
of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients 
with and without neuropathy. Diabetes Care, 24(2), 344-349.  
 
Hatoum, O. A., Otterson, M. F., Kopelman, D., Miura, H., Sukhotnik, I., Larsen, B. T., . . . 
Gutterman, D. D. (2006). Radiation induces endothelial dysfunction in murine intestinal 
arterioles via enhanced production of reactive oxygen species. Arterioscler Thromb Vasc 
Biol, 26(2), 287-294. doi:10.1161/01.ATV.0000198399.40584.8c 
 
Haubner, F., Ohmann, E., Pohl, F., Strutz, J., & Gassner, H. G. (2012). Wound healing after 
radiation therapy: review of the literature. Radiat Oncol, 7, 162. doi:10.1186/1748-717X-
7-162 
 
Heitzer, T., Schlinzig, T., Krohn, K., Meinertz, T., & Münzel, T. (2001). Endothelial 
dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary 
artery disease. Circulation, 104(22), 2673-2678.  
 
Holler, V., Buard, V., Gaugler, M. H., Guipaud, O., Baudelin, C., Sache, A., . . . Benderitter, M. 
(2009). Pravastatin limits radiation-induced vascular dysfunction in the skin. J Invest 
Dermatol, 129(5), 1280-1291. doi:10.1038/jid.2008.360 
 
Holowatz, L. A., Thompson, C. S., Minson, C. T., & Kenney, W. L. (2005). Mechanisms of 
acetylcholine-mediated vasodilatation in young and aged human skin. J Physiol, 563(Pt 
3), 965-973. doi:10.1113/jphysiol.2004.080952 
 
Hooning, M. J., Botma, A., Aleman, B. M., Baaijens, M. H., Bartelink, H., Klijn, J. G., . . . van 
Leeuwen, F. E. (2007). Long-term risk of cardiovascular disease in 10-year survivors of 
breast cancer. J Natl Cancer Inst, 99(5), 365-375. doi:10.1093/jnci/djk064 
 
Hull, M. C., Morris, C. G., Pepine, C. J., & Mendenhall, N. P. (2003). Valvular dysfunction and 
21 
carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma 
treated with radiation therapy. JAMA, 290(21), 2831-2837. 
doi:10.1001/jama.290.21.2831 
 
Jacobson, L. K., Johnson, M. B., Dedhia, R. D., Niknam-Bienia, S., & Wong, A. K. (2017). 
Impaired wound healing after radiation therapy: A systematic review of parthogenesis 
and treatment. In (Vol. 13, pp. 92-105): JPRAS Open. 
 
Jaschke, W., Schmuth, M., Trianni, A., & Bartal, G. (2017). Radiation-Induced Skin Injuries to 
Patients: What the Interventional Radiologist Needs to Know. Cardiovasc Intervent 
Radiol, 40(8), 1131-1140. doi:10.1007/s00270-017-1674-5 
 
Kellogg, D. L., Zhao, J. L., Coey, U., & Green, J. V. (2005). Acetylcholine-induced vasodilation 
is mediated by nitric oxide and prostaglandins in human skin. J Appl Physiol (1985), 
98(2), 629-632. doi:10.1152/japplphysiol.00728.2004 
 
Khan, F., Davidson, N. C., Littleford, R. C., Litchfield, S. J., Struthers, A. D., & Belch, J. J. 
(1997). Cutaneous vascular responses to acetylcholine are mediated by a prostanoid-
dependent mechanism in man. Vasc Med, 2(2), 82-86. 
doi:10.1177/1358863X9700200202 
 
Khan, F., Patterson, D., Belch, J. J., Hirata, K., & Lang, C. C. (2008). Relationship between 
peripheral and coronary function using laser Doppler imaging and transthoracic 
echocardiography. Clin Sci (Lond), 115(9), 295-300. doi:10.1042/CS20070431 
 
Lee, M. S., Finch, W., & Mahmud, E. (2013). Cardiovascular complications of radiotherapy. Am 
J Cardiol, 112(10), 1688-1696. doi:10.1016/j.amjcard.2013.07.031 
 
Lee, P. C., Salyapongse, A. N., Bragdon, G. A., Shears, L. L., Watkins, S. C., Edington, H. D., & 
Billiar, T. R. (1999). Impaired wound healing and angiogenesis in eNOS-deficient mice. 
Am J Physiol, 277(4), H1600-1608. doi:10.1152/ajpheart.1999.277.4.H1600 
 
Loader, J., Roustit, M., Taylor, F., MacIsaac, R. J., Stewart, S., Lorenzen, C., & Walther, G. 
(2017). Assessing cutaneous microvascular function with iontophoresis: Avoiding non-
specific vasodilation. Microvasc Res, 113, 29-39. doi:10.1016/j.mvr.2017.04.006 
 
Maynard, K. I., Stewart-Lee, A. L., Milner, P., & Burnstock, G. (1992). X-irradiation attenuates 
relaxant responses in the rabbit ear artery. Br J Pharmacol, 105(1), 126-128.  
 
Medow, M. S., Glover, J. L., & Stewart, J. M. (2008). Nitric oxide and prostaglandin inhibition 
during acetylcholine-mediated cutaneous vasodilation in humans. Microcirculation, 
15(6), 569-579. doi:10.1080/10739680802091526 
 
Medow, M. S., Minson, C. T., & Stewart, J. M. (2005). Decreased microvascular nitric oxide-




Mendonca, M. S., Chin-Sinex, H., Dhaemers, R., Mead, L. E., Yoder, M. C., & Ingram, D. A. 
(2011). Differential mechanisms of x-ray-induced cell death in human endothelial 
progenitor cells isolated from cord blood and adults. Radiat Res, 176(2), 208-216.  
 
Menendez, J. C., Casanova, D., Amado, J. A., Salas, E., García-Unzueta, M. T., Fernandez, F., . . 
. Berrazueta, J. R. (1998). Effects of radiation on endothelial function. Int J Radiat Oncol 
Biol Phys, 41(4), 905-913.  
 
Michaelson, M. D., Cotter, S. E., Gargollo, P. C., Zietman, A. L., Dahl, D. M., & Smith, M. R. 
(2008). Management of complications of prostate cancer treatment. CA Cancer J Clin, 
58(4), 196-213. doi:10.3322/CA.2008.0002 
 
Noon, J. P., Walker, B. R., Hand, M. F., & Webb, D. J. (1998). Studies with iontophoretic 
administration of drugs to human dermal vessels in vivo: cholinergic vasodilatation is 
mediated by dilator prostanoids rather than nitric oxide. Br J Clin Pharmacol, 45(6), 545-
550.  
 
On, Y. K., Kim, H. S., Kim, S. Y., Chae, I. H., Oh, B. H., Lee, M. M., . . . Chung, M. H. (2001). 
Vitamin C prevents radiation-induced endothelium-dependent vasomotor dysfunction and 
de-endothelialization by inhibiting oxidative damage in the rat. Clin Exp Pharmacol 
Physiol, 28(10), 816-821.  
 
Paszat, L. F., Vallis, K. A., Benk, V. M., Groome, P. A., Mackillop, W. J., & Wielgosz, A. 
(2007). A population-based case-cohort study of the risk of myocardial infarction 
following radiation therapy for breast cancer. Radiother Oncol, 82(3), 294-300. 
doi:10.1016/j.radonc.2007.01.004 
 
Patik, J. C., Christmas, K. M., Hurr, C., & Brothers, R. M. (2016). Impaired endothelium 
independent vasodilation in the cutaneous microvasculature of young obese adults. 
Microvasc Res, 104, 63-68. doi:10.1016/j.mvr.2015.11.007 
 
Qi, F., Sugihara, T., Hattori, Y., Yamamoto, Y., Kanno, M., & Abe, K. (1998). Functional and 
morphological damage of endothelium in rabbit ear artery following irradiation with 
cobalt60. Br J Pharmacol, 123(4), 653-660. doi:10.1038/sj.bjp.0701654 
 
Rodriguez-Miguelez, P., Thomas, J., Seigler, N., Crandall, R., McKie, K. T., Forseen, C., & 
Harris, R. A. (2016). Evidence of microvascular dysfunction in patients with cystic 
fibrosis. Am J Physiol Heart Circ Physiol, 310(11), H1479-1485. 
doi:10.1152/ajpheart.00136.2016 
 
Rossi, M., & Carpi, A. (2004). Skin microcirculation in peripheral arterial obliterative disease. 
Biomed Pharmacother, 58(8), 427-431. doi:10.1016/j.biopha.2004.08.004 
 
Schäffer, M., Weimer, W., Wider, S., Stülten, C., Bongartz, M., Budach, W., & Becker, H. D. 
(2002). Differential expression of inflammatory mediators in radiation-impaired wound 
23 
healing. J Surg Res, 107(1), 93-100.  
 
Seddon, B., Cook, A., Gothard, L., Salmon, E., Latus, K., Underwood, S. R., & Yarnold, J. 
(2002). Detection of defects in myocardial perfusion imaging in patients with early breast 
cancer treated with radiotherapy. Radiother Oncol, 64(1), 53-63.  
 
Senkus-Konefka, E., & Jassem, J. (2007). Cardiovascular effects of breast cancer radiotherapy. 
Cancer Treat Rev, 33(6), 578-593. doi:10.1016/j.ctrv.2007.07.011 
 
Soloviev, A. I., Tishkin, S. M., Parshikov, A. V., Ivanova, I. V., Goncharov, E. V., & Gurney, A. 
M. (2003). Mechanisms of endothelial dysfunction after ionized radiation: selective 
impairment of the nitric oxide component of endothelium-dependent vasodilation. Br J 
Pharmacol, 138(5), 837-844. doi:10.1038/sj.bjp.0705079 
 
Sugihara, T., Hattori, Y., Yamamoto, Y., Qi, F., Ichikawa, R., Sato, A., . . . Kanno, M. (1999). 
Preferential impairment of nitric oxide-mediated endothelium-dependent relaxation in 
human cervical arteries after irradiation. Circulation, 100(6), 635-641.  
 
Sutterfield, S. L., Caldwell, J. T., Post, H. K., Lovoy, G. M., Banister, H. R., & Ade, C. J. 
(2018). Lower cutaneous microvascular reactivity in adult cancer patients receiving 
chemotherapy. J Appl Physiol (1985), 125(4), 1141-1149. 
doi:10.1152/japplphysiol.00394.2018 
 
Vassilakopoulou, M., Mountzios, G., Papamechael, C., Protogerou, A. D., Aznaouridis, K., 
Katsichti, P., . . . Papadimitriou, C. A. (2010). Paclitaxel chemotherapy and vascular 
toxicity as assessed by flow-mediated and nitrate-mediated vasodilatation. Vascul 
Pharmacol, 53(3-4), 115-121. doi:10.1016/j.vph.2010.05.002 
 
Venkatesulu, B. P., Mahadevan, L. S., Aliru, M. L., Yang, X., Bodd, M. H., Singh, P. K., . . . 
Krishnan, S. (2018). Radiation-Induced Endothelial Vascular Injury: A Review of 
Possible Mechanisms. JACC Basic Transl Sci, 3(4), 563-572. 
doi:10.1016/j.jacbts.2018.01.014 
 
Verma, S., Buchanan, M. R., & Anderson, T. J. (2003). Endothelial function testing as a 
biomarker of vascular disease. Circulation, 108(17), 2054-2059. 
doi:10.1161/01.CIR.0000089191.72957.ED 
 
Walther, G., Obert, P., Dutheil, F., Chapier, R., Lesourd, B., Naughton, G., . . . Vinet, A. (2015). 
Metabolic syndrome individuals with and without type 2 diabetes mellitus present 
generalized vascular dysfunction: cross-sectional study. Arterioscler Thromb Vasc Biol, 
35(4), 1022-1029. doi:10.1161/ATVBAHA.114.304591 
 
